— Le Journal RENASCOR · Dossier

CAR-T Cell Therapy: A Revolution in Cancer Treatment

CAR-T cell therapy involves reprogramming a patient's T lymphocytes to target and destroy cancer cells. A revolutionary innovation in immunotherapy, with spectacular results in certain leukemias and lymphomas.<\/p>

CAR-T Cell Therapy: A Revolution in Cancer Treatment

A New Era for Immunotherapy

For about a decade, immunotherapy has transformed the management of certain cancers. Among the most promising innovations is CAR-T cell therapy (Chimeric Antigen Receptor T-cells).

This is a cutting-edge treatment that mobilizes the patient's own immune defenses, reprogrammed to specifically attack tumor cells.

How Does CAR-T Treatment Work?
  1. Collection of T Lymphocytes: the patient's immune cells are collected through a procedure similar to a blood draw.

  2. Genetic Modification: in the laboratory, these lymphocytes are modified to express an artificial receptor (CAR) capable of recognizing a specific antigen present on the surface of cancer cells.

  3. Cell Expansion: the reprogrammed cells are multiplied by millions.

  4. Reinjection: they are then reinjected into the patient to selectively destroy tumor cells.

    In Which Cancers?

    CAR-T cells are currently used in certain resistant or relapsed hematological malignancies, including:

    • Acute Lymphoblastic Leukemia (children and young adults)

    • Diffuse Large B-Cell Lymphoma

    • Multiple Myeloma

      New clinical trials are gradually expanding the scope to other hematological cancers and, eventually, perhaps to solid tumors.

      Observed Benefits
      • Complete remissions in patients with no other therapeutic alternatives.

      • Very precise targeting of diseased cells.

      • Sometimes a single injection may be sufficient, unlike chronic treatments.

        Current Limitations and Challenges
        • Sometimes severe side effects, such as cytokine release syndrome or neurological impairments.

        • An extremely high cost, often exceeding €300,000 per treatment.

        • A complex production process, requiring highly specialized laboratories.

          And After Treatment?

          Even though CAR-T cells represent a major advancement, patients often face physical and psychological side effects. Reconstruction, particularly hair restoration, remains an important step in moving past the disease.

          This is precisely where Laboratory RENASCOR comes in, a global specialist in post-cancer hair restoration. With its unique care, we support patients beyond the therapeutic protocol, helping them regain confidence, identity, and quality of life.

— À lire ensuite —

Articles similaires